Shareholders Approve New Equity Incentive Plan Authorizing 7 Million Shares
ALTO has more than doubled off its 52-week low of $0.917.
Summary
Alto Ingredients shareholders approved a new 2026 Omnibus Incentive Plan, authorizing the issuance of up to 7 million shares for equity awards, which could result in approximately 9% potential dilution.
Key Events · Financing and Capital Events · ALTO
-
2026 Omnibus Incentive Plan Approved
Shareholders approved the 2026 Omnibus Incentive Plan, authorizing the company to issue up to 7,000,000 shares of common stock for equity and equity-based awards. This represents a potential dilution of approximately 9% if all authorized shares were issued.
-
Directors Elected
Five directors (Gilbert E. Nathan, Bryon T. McGregor, Dianne S. Nury, Maria G. Gray, and Alan R. Tank) were elected to the Board of Directors.
-
Executive Compensation and Auditor Ratified
Shareholders approved the 2025 compensation for named executive officers and ratified RSM US LLP as the independent registered public accounting firm for 2026.
Analysis · ALTO · Industrial Applications And Services
Shareholders have approved the 2026 Omnibus Incentive Plan, authorizing the company to issue up to 7,000,000 shares for equity and equity-based awards. This authorization represents a potential dilution of approximately 9% if all shares were issued, creating a significant overhang for existing shareholders. This filing finalizes the terms of the incentive plan that was initially proposed in the DEF 14A filed on April 30, 2026.
At the time of this filing, ALTO was trading at $5.10 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $396M. The 52-week trading range was $0.92 to $6.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.